HEXO vs. Sundial: Which Canadian Cannabis Stock Is a Buy Right Now?

Shares of HEXO and Sundial are both down over 90% from all-time highs. Which between the two is a better contrarian bet for investors?

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

After more than two years of underperforming the markets, investors will be hoping for Canadian cannabis stocks to gain momentum by the end of 2021. A majority of marijuana players in Canada were hit by a slew of structural issues as well as the ongoing pandemic in addition to constant equity capital raises that diluted shareholder wealth significantly.

Several cannabis producers are looking to narrow their losses by focusing on supply chain improvements as well as selling high-margin products. Here, we compare HEXO (TSX:HEXO)(NYSE:HEXO) and Sundial (NASDAQ:SNDL) to see which is a better stock to buy right now.

HEXO stock is down 34% in 2021

Shares of HEXO have declined by 34% in the first eight months of 2021. It’s also down 93% from record highs, offering investors a chance to buy the dip. The cannabis giant has managed to increase sales from $4.93 million in fiscal 2018 to $80.7 million in fiscal 2020 that ended in July. Now, analysts expect HEXO sales to touch $128 million in fiscal 2021 and $256 million in 2022.

However, despite the company’s stellar top-line growth, HEXO continues to remain unprofitable. In fact, in 2020, it reported a gross loss of $58 million and an operating loss of $163 million.

HEXO’s stellar revenue growth forecast for the next four quarters will be on the back of the company’s acquisitions this year. In the first six months of CY 2021, HEXO disclosed three big-ticket acquisitions, including Redecan, which is Canada’s largest privately held cannabis producer.

Analysts also expect HEXO’s bottom line to improve from a loss per share of $7.08 in fiscal 2020 to a loss of $0.12 per share in 2021. Given the stock has 201 million shares outstanding, its total losses in 2022 will be around $24 million. It ended the quarter ended in May with a cash balance of $81 million and will have to raise additional capital to fund its acquisitions and cash burn.

HEXO stock, in fact, fell over 25% on Aug. 20 after the company announced it will raise additional capital at an offering of $2.95 per unit.

Sundial stock is down 94% from record highs

After going public two years back, Sundial stock is down 94% from record highs. While HEXO is targeting inorganic growth to gain traction in a highly competitive market, Sundial is looking to pivot its business.

Sundial has already reduced its product portfolio to improve profitability. It has also entered the cannabis financing space to provide capital to other marijuana companies. Between September 2020 and February 2021 Sundial issued 1.15 billion shares, which have increased its total share count to more than two billion.

One thing going right for Sundial is, the company is debt-free, and with a cash balance of $986 million, it has enough room to improve profitability going forward.

The Foolish takeaway

We can see that both HEXO and Sundial will remain volatile in the near term. But HEXO’s recent acquisitions and rising market share make it a better bet compared to Sundial, which is revamping its business model.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?

Cronos Group remains a high-risk, high-reward stock, despite its solid first-quarter performance.

Read more »

Cannabis smoke
Cannabis Stocks

Aurora Cannabis Stock Hits 52-Week Low: What Investors Should Know

Aurora Cannabis stock continues to fall, hitting a yearly bottom last week. So what should investors do now?

Read more »

edit Jars of marijuana
Cannabis Stocks

Here’s Why Curaleaf Is a Better Cannabis Stock Compared to Sundial!

Cannabis giant Curaleaf ended 2021 with $1.2 billion in sales, making it one of the largest marijuana companies in the…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Cannabis Stocks Better Than Sundial Growers

Here's why Green Thumb Industries and Cresco Labs are much better long-term bets compared to Sundial Growers.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Hexo Stock Jumps 10% on Definitive Tilray Deal

Hexo (TSX:HEXO)(NASDAQ:HEXO) stock jumped 10% on Monday, as its deal with Tilray (TSX:TLRY)(NASDAQ:TLRY) stock became official.

Read more »

edit Jars of marijuana
Cannabis Stocks

Down 97% From Record Highs, Is Sundial Stock a Buy Right Now?

Despite the 97% decline in Sundial stock from its record high, it remains a risky bet for long-term investors due…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Tilray Stock Rallied After its Q3 Results

Here's why Tilray (TSX:TLRY) stock jumped sharply after announcing its Q3 results.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Tuesday, March 29

TSX investors may want to keep an eye on the latest consumer confidence and job openings data from the U.S.…

Read more »